National Health Investors Q2 2024 Normalized FFO $1.18 Beats $1.10 Estimate, Sales $84.970M Beat $81.347M Estimate
Portfolio Pulse from Benzinga Newsdesk
National Health Investors (NYSE:NHI) reported Q2 2024 Normalized FFO of $1.18 per share, beating the analyst estimate of $1.10. Sales were $84.970 million, surpassing the $81.347 million estimate. Both FFO and sales showed significant year-over-year growth.
August 06, 2024 | 8:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
National Health Investors (NYSE:NHI) reported Q2 2024 Normalized FFO of $1.18 per share, beating the analyst estimate of $1.10. Sales were $84.970 million, surpassing the $81.347 million estimate. Both FFO and sales showed significant year-over-year growth.
NHI's Q2 2024 earnings and sales both exceeded analyst expectations and showed strong year-over-year growth. This positive financial performance is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100